Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs71115955 | chr14:74559018 | GT/G | 2.24E-5 | 176 | 25.4 | 27.43 | 10.3 | KM Plot |
PCPG | rs71115960 | chr14:74586010 | GC/G | 4.4E-7 | 177 | 25.4 | 27.78 | 7.4 | KM Plot |
PCPG | rs71139192 | chr17:65776315 | AT/ATT | 0.000445 | 173 | 25.2 | 31.9 | 8.22 | KM Plot |
PCPG | rs71150407 | chr3:125556658 | CCTTTCTCCTCACCT/C | 0.000379 | 173 | 25.53 | 31.9 | 6.1 | KM Plot |
PCPG | rs7116655 | chr11:103963380 | G/C | 5.71E-11 | 176 | 25.87 | 18.57 | 10.3 | KM Plot |
PCPG | rs71207989 | chr2:24343147 | A/ACAAC | 3.22E-6 | 176 | 25.53 | 26.57 | 17.43 | KM Plot |
PCPG | rs7127084 | chr11:1533682 | C/T | 0.000149 | 178 | 25.28 | 25.43 | 15.22 | KM Plot |
PCPG | rs71297105 | chr7:89857725 | A/AAAC | 3.1E-5 | 177 | 25.77 | 24.53 | 6.15 | KM Plot |
PCPG | rs71299622 | chr3:52917038 | G/A | 8.4E-6 | 174 | 25.4 | 26.05 | 10.3 | KM Plot |
PCPG | rs71301808 | chr3:53085577 | C/G | 0.000137 | 175 | 25.08 | 26.92 | 10.3 | KM Plot |
PCPG | rs71301809 | chr3:53090312 | C/T | 7.36E-6 | 174 | 25.08 | 30.87 | 11.78 | KM Plot |
PCPG | rs71301811 | chr3:53099334 | T/C | 7.12E-6 | 176 | 25.08 | 26.92 | 11.78 | KM Plot |
PCPG | rs71301814 | chr3:53117663 | G/A | 7.77E-6 | 176 | 25.28 | 26.05 | 11.78 | KM Plot |
PCPG | rs71305806 | chr14:74391386 | C/CT | 1.35E-5 | 174 | 25.4 | 27.2 | 10.43 | KM Plot |
PCPG | rs71310118 | chr2:24336825 | G/GCTGA | 0.000114 | 177 | 25.28 | 27.27 | 17.43 | KM Plot |